DAYU BIOLOGICAL
871970
KLT
831689
Fujian Superpipe
300198
4
WuHan Hvsen Biotechnology
300871
5
Ningxia Xiaoming Agriculture&Animal Husbandry
300967
CN Stock MarketDetailed Quotes
600785 Yinchuan Xinhua Commercial
- 11.94
- +0.30+2.58%
Trading Mar 26 14:33 CST
2.69BMarket Cap19.97P/E (TTM)
12.19High11.60Low99.37KlotVolume11.70Open11.64Pre Close118.40MTurnover4.40%Turnover Ratio19.97P/E (Static)225.63MShares20.3252wk High1.20P/B2.69BFloat Cap8.6352wk Low12.80Limit Up225.63MShs Float36.46Historical High10.48Limit Down5.07%Amplitude-0.26Historical Low0.20Dividend TTM11.91Avg Price46.16KlotAsk1.68%Div YieldTTM100Lot Size52.02KlotBid
Yinchuan Xinhua Commercial Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -2.01%6.11B | -0.40%5.95B | 0.94%4.04B | -1.33%2.29B | 6.31%6.23B | 2.42%5.98B | 1.82%4.01B | 4.51%2.32B | 6.16%5.86B | 1.17%5.84B |
| Refunds of taxes and levies | --14.51M | --14.61M | ---- | ---- | ---- | ---- | ---- | ---- | --7.43M | ---- |
| Cash received relating to other operating activities | -6.84%424.72M | -35.47%382.83M | -37.97%256.69M | -35.83%137.07M | 23.79%455.9M | 11.15%593.25M | 5.77%413.83M | -1.56%213.62M | -4.67%368.28M | -14.72%533.76M |
| Cash inflows from operating activities | -2.13%6.54B | -3.34%6.35B | -2.70%4.3B | -4.24%2.43B | 7.21%6.69B | 3.16%6.57B | 2.17%4.42B | 3.97%2.53B | 5.57%6.24B | -0.39%6.37B |
| Goods services cash paid | -0.80%4.44B | -2.55%4.74B | -0.93%3.34B | -1.10%1.84B | 2.60%4.48B | 1.03%4.87B | 1.25%3.37B | 2.33%1.86B | 8.56%4.36B | -1.17%4.82B |
| Staff behalf paid | -9.11%478.62M | 3.40%416.89M | 4.99%293.44M | 10.31%173.69M | 19.38%526.6M | 2.33%403.18M | -3.19%279.48M | -4.51%157.46M | -12.85%441.13M | -8.77%394.01M |
| All taxes paid | -0.21%202.86M | -1.07%151.94M | 4.67%99.08M | 8.54%61.41M | 6.05%203.29M | 4.71%153.58M | -5.12%94.66M | -18.73%56.58M | 22.48%191.69M | 30.74%146.68M |
| Cash paid relating to other operating activities | 4.27%574.93M | 9.48%429.36M | 16.85%288.82M | 20.06%146.52M | 6.78%551.39M | 10.15%392.19M | 3.97%247.17M | -0.08%122.04M | 10.69%516.38M | -0.58%356.05M |
| Cash outflows from operating activities | -1.05%5.7B | -1.28%5.74B | 0.71%4.02B | 1.15%2.22B | 4.46%5.76B | 1.79%5.82B | 0.93%4B | 1.00%2.19B | 7.07%5.51B | -1.08%5.71B |
| Net cash flows from operating activities | -8.78%846.61M | -19.20%609.74M | -34.94%275.27M | -38.74%209.6M | 28.22%928.1M | 15.09%754.68M | 15.65%423.13M | 28.15%342.17M | -4.59%723.82M | 6.12%655.71M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 108.97%695.88M | 95.83%420.06M | 53.14%295.56M | 54.76%65M | 50.82%333M | 56.71%214.5M | 286.00%193M | -16.00%42M | -75.54%220.8M | -83.87%136.88M |
| Cash received from returns on investments | 256.47%7.25M | 529.28%3.92M | 452.41%3.24M | 141.18%113.23K | 61.98%2.03M | -98.81%623.18K | 67.12%585.95K | -86.61%46.95K | -26.68%1.26M | 4,066.04%52.35M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -81.21%2.94M | -89.88%1.54M | -95.06%732.5K | -98.01%280.42K | 484.60%15.65M | 1,804.97%15.26M | 2,041.76%14.82M | 10,721.66%14.07M | -47.89%2.68M | -60.79%800.93K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --49.07K |
| Cash inflows from investing activities | 101.34%706.07M | 84.71%425.53M | 43.72%299.53M | 16.53%65.39M | 56.05%350.68M | 21.21%230.38M | 307.91%208.41M | 11.16%56.12M | -75.82%224.73M | -77.69%190.07M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -20.30%283.92M | 4.73%237.57M | 23.17%186.67M | 10.98%90.18M | 15.32%356.24M | -2.69%226.85M | 9.67%151.55M | 68.39%81.25M | 0.78%308.93M | 7.76%233.12M |
| Cash paid to acquire investments | 42.88%679.32M | 53.14%445.64M | 39.08%265.64M | 44.00%144M | 357.14%475.43M | 168.55%291M | 238.90%191M | 77.43%100M | -87.94%104M | -87.74%108.36M |
| Cash outflows from investing activities | 15.82%963.23M | 31.93%683.22M | 32.04%452.31M | 29.20%234.18M | 101.41%831.67M | 51.65%517.85M | 76.07%342.55M | 73.26%181.25M | -64.66%412.93M | -68.95%341.48M |
| Net cash flows from investing activities | 46.53%-257.16M | 10.36%-257.69M | -13.89%-152.78M | -34.88%-168.78M | -155.58%-480.99M | -89.86%-287.47M | 6.49%-134.14M | -131.17%-125.13M | 21.32%-188.19M | 38.91%-151.41M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --1.5M | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%100K | 0.00%100K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --1.5M | --1.5M | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%100K | 0.00%100K |
| Cash from borrowing | -15.89%1.05B | -3.29%927.4M | -5.72%688M | -21.95%145M | -10.01%1.25B | -19.68%958.98M | -27.43%729.74M | 13.18%185.78M | 0.97%1.39B | 16.59%1.19B |
| Cash received relating to other financing activities | -9.23%55.98M | 36.99%75.5M | 22.56%67.55M | -54.34%9.88M | -53.58%61.67M | -57.76%55.11M | -57.58%55.11M | -75.19%21.65M | -25.50%132.85M | -0.94%130.49M |
| Cash inflows from financing activities | -15.46%1.11B | -0.96%1B | -3.73%755.55M | -25.33%154.88M | -13.82%1.31B | -23.44%1.01B | -30.89%784.85M | -17.49%207.42M | -2.07%1.52B | 14.59%1.32B |
| Borrowing repayment | -7.09%1.19B | -4.06%1.03B | -5.16%686.75M | 244.46%157.76M | -16.55%1.28B | -13.67%1.07B | -17.82%724.15M | -88.62%45.8M | -10.01%1.54B | -9.25%1.24B |
| Dividend interest payment | 38.24%73.64M | 46.26%67.22M | 55.20%59.68M | -12.04%7.29M | 68.79%53.27M | 76.81%45.96M | 127.25%38.45M | -1.44%8.28M | -12.12%31.56M | -15.00%26M |
| Cash payments relating to other financing activities | 13.58%482.63M | -12.43%361.14M | -29.36%207.23M | -43.51%75.97M | 12.58%424.93M | 5.07%412.42M | 30.84%293.34M | 40.89%134.5M | -47.60%377.44M | -20.12%392.52M |
| Cash outflows from financing activities | -0.74%1.75B | -4.80%1.46B | -9.69%953.66M | 27.80%241.02M | -9.53%1.76B | -7.81%1.53B | -5.92%1.06B | -62.75%188.59M | -21.02%1.95B | -12.17%1.66B |
| Net cash flows from financing activities | -42.22%-639.89M | 12.39%-450.71M | 26.92%-198.11M | -557.25%-86.14M | -5.86%-449.93M | -54.24%-514.44M | -2,136.21%-271.09M | 107.39%18.84M | 53.36%-425.03M | 54.43%-333.54M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -35.06%123.43 |
| Net increase in cash and cash equivalents | -1,683.57%-50.44M | -108.90%-98.65M | -522.43%-75.62M | -119.21%-45.32M | -102.56%-2.83M | -127.66%-47.22M | -92.41%17.9M | 661.59%235.88M | 128.23%110.6M | 147.19%170.76M |
| Add:Begin period cash and cash equivalents | -0.72%389.53M | -0.72%389.53M | -0.72%389.53M | -0.72%389.53M | 39.25%392.36M | 39.25%392.36M | 39.25%392.36M | 39.25%392.36M | -58.17%281.76M | -58.17%281.76M |
| End period cash equivalent | -12.95%339.1M | -15.72%290.88M | -23.48%313.92M | -45.21%344.22M | -0.72%389.53M | -23.73%345.14M | -20.72%410.26M | 162.02%628.24M | 39.25%392.36M | 45.19%452.53M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.